Search papers, labs, and topics across Lattice.
This study introduces CounterFundus, a CycleGAN-based counterfactual explainability framework that enhances the interpretability of deep learning models used for retinal disease classification. By generating visually plausible disease-to-normal fundus image translations, the framework links model decisions to clinically relevant retinal regions, addressing a significant barrier to clinical adoption of AI in ophthalmology. The introduction of the Counterfactual-Classifier Alignment Score (CCAS) quantitatively assesses the spatial alignment of counterfactual explanations with classifier saliency, demonstrating improved classification performance and consistency across evaluation metrics.
CounterFundus not only clarifies model decisions in retinal disease classification but also boosts classification accuracy through its innovative counterfactual explanations.
Automated detection of vision impairing retina-based ocular conditions from fundus images is important for early screening, timely referral and reducing dependency on specialist-only assessment, for which neural network-based deep learning (DL) models have been widely utilized. However, explainability of the DL frameworks remains a major bottleneck for clinical adoption, particularly when model decisions are not linked to retinal regions that are clinically meaningful. To address this issue, this study presents CounterFundus, a novel CycleGAN-driven counterfactual explainability framework, integrating EfficientNet-B5-based retinal disease detection with visually interpretable disease-to-normal fundus image translation. For each pathological image, the counterfactual yielded by the CycleGAN generator represents an estimated healthy counterpart and the resultant difference map is utilized to localize disease-associated retinal changes. Unlike conventional post-hoc saliency methods, CounterFundus provides counterfactual explanations through visually plausible disease-to-normal retinal translation. Thereafter, to quantify the spatial agreement between counterfactual difference maps and classifier saliency, the Counterfactual-Classifier Alignment Score (CCAS) is introduced, embedding Spearman correlation, binary IoU and pointing accuracy into a single assessment protocol. To this end, EigenCAM-aligned evaluation demonstrates that the generated counterfactual explanations remain spatially consistent with classifier-relevant retinal evidence across all CCAS dimensions. Along with that, ablation studies further confirm that CCAS-filtered counterfactual augmentation improves the downstream classification performance in fundus images, establishing CounterFundus as a clinically-grounded, explainable artificially intelligence (XAI) framework for retinal disease detection.
